ArticleHealth & justice2025
Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder.
Article in Health & justice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reducing Buprenorphine Misinformation as a Strategy to Improve Adoption in Primary Care.Substance use & misuse · 2026Article
- "Convenience, Quickness, and Compassion": Experiences of People Involved in the Criminal-Legal System Accessing Medications for Opioid Use Disorder Services From a Mobile Unit in Chicago.Health expectations : an international journal of public participation in health care and health policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCriminal legal involved (CLI) individuals face a heightened risk of opioid misuse and overdose, yet access to medications for opioid use disorder (MOUD) is limited, particularly in criminal legal settings. Negative attitudes and misinformation about MOUD are prevalent among legal system actors, creating a barrier to MOUD access. This study examines the effectiveness of informational and narrative messages in correcting misinformation and promoting positive attitudes toward MOUD among criminal legal system (CLS) professionals.
methodUsing state/federal websites, social media groups, and professional connections to correctional and behavioral health agencies nationwide, we recruited individuals who were currently working in corrections and behavioral health in criminal legal settings in the United States (N = 502). An online experiment was conducted with four message conditions: no message control, informational message, first-person narrative message, and dialogue message. The study assessed attitudes toward MOUD use and support for greater access in these settings, as well as information processing outcomes including narrative transportation (i.e., becoming immersed in a story), perceived realism, and counterarguing.
resultsCompared to no message control, both the first-person narrative message (p = .006) and the dialogue message (p = .026) produced more positive attitudes toward MOUD; the informational message marginally improved positive attitudes (p = .080). The dialogue message also increased support for MOUD access in jails/prisons compared to control (p = .003). Neither the narrative nor the informational messages significantly reduced negative attitudes. The first-person (p = .050) and dialogue (p = .030) messages both generated significantly greater transportation compared to the informational message.
conclusionBoth informational and narrative messages can improve attitudes toward MOUD use in criminal legal settings. Well-designed educational messages aimed at changing attitudes and reducing barriers to promoting MOUD use in criminal legal settings are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.